Pritelivir EAP

Trial ID: NCT05844436

Interventional - EAP - Available

EAP: treatment for immunocompromissed patients with treatment resistant HSV type 1 and 2

Conditions

1. immunocompromised
2. acyclovir resistant and foscarnet resistant/intolerant or acyclovir resistant and previously treated in PRIOH-1 part C
3. HSV positive lesion
4. active lesion
5. willing to use effective birth control
6. negative pregnancy test
7. consent

1. eligbility for CT with pritelivir
2. known intolerance to protelivri or excipients
3. use of proibithed concomitant medications
4. baseline safety laboratories abnormalities
5. history or evidence of gastrointestinal malabsorption
6. hemodialysis
7. history or evidence of cardiovascular, pulmonary, hepatic, renal, GI, hematological, endocrinological, metabolic, neurological, psychiatric, or other dieases that may affect patient's safety
8. abnormalities in hematological laboratory variables
9. not able to communicate
10. pregnant or breastfeeding

AiCuris Anti-infective Cures